The Cooper Companies, Inc. (COO)
US — Healthcare Sector
Automate Your Wheel Strategy on COO
With Tiblio's Option Bot, you can configure your own wheel strategy including COO - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol COO
- Rev/Share 20.168
- Book/Share 41.6401
- PB 1.7879
- Debt/Equity 0.2967
- CurrentRatio 2.1164
- ROIC 0.0428
- MktCap 14852920326.0
- FreeCF/Share 2.0533
- PFCF 36.0595
- PE 36.6225
- Debt/Assets 0.2002
- DivYield 0
- ROE 0.0497
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 4
- P/B Score 4
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | COO | Barclays | -- | Overweight | -- | $85 | Oct. 13, 2025 |
| Initiation | COO | Goldman | -- | Sell | -- | $64 | Oct. 1, 2025 |
| Downgrade | COO | Citigroup | Buy | Neutral | -- | $72 | Aug. 28, 2025 |
| Upgrade | COO | BNP Paribas Exane | Neutral | Outperform | -- | $92 | July 22, 2025 |
| Upgrade | COO | Needham | Hold | Buy | -- | $94 | June 17, 2025 |
| Downgrade | COO | JP Morgan | Overweight | Neutral | -- | $76 | May 30, 2025 |
| Reiterated | COO | Piper Sandler | -- | Overweight | $115 | $120 | Aug. 29, 2024 |
News
What Analyst Projections for Key Metrics Reveal About The Cooper Companies (COO) Q1 Earnings
COO
Published: March 03, 2025 by: Zacks Investment Research
Sentiment: Positive
Published: March 03, 2025 by: Zacks Investment Research
Sentiment: Positive
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for The Cooper Companies (COO), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended January 2025.
Read More
About The Cooper Companies, Inc. (COO)
- IPO Date 1983-01-21
- Website https://www.coopercos.com
- Industry Medical - Instruments & Supplies
- CEO Albert G. White III
- Employees 16000
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.